Blueshift Asset Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$28.51 - $32.9 $443,615 - $511,924
-15,560 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$26.37 - $34.22 $410,317 - $532,463
15,560 New
15,560 $454,000
Q1 2019

May 14, 2019
SELL
$32.77 - $41.99 $268,845 - $344,485
-8,204 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$30.84 - $49.51 $253,011 - $406,180
8,204 New
8,204 $273,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email